Court Square and Pamlico Capital Invest in AVANT

Pamlico Capital Announces Strategic Growth Investment in AVANT

October 22, 2021

IT Services

Pamlico Capital provided a strategic growth investment in AVANT to accelerate the Chicago-based IT distributor's expansion and scale its platform for IT decision-making. AVANT's founders and management retain significant ownership and will continue to run the business as the company grows hiring and expands capabilities across cloud, security and UCaaS offerings.

Staple Street Affiliate Acquires Avante Health Solutions

February 14, 2025

Medical Devices

An affiliate of private equity firm Staple Street Capital Group, LLC has acquired Avante Health Solutions after the company exited bankruptcy. The transaction eliminates third‑party debt, consolidates Avante’s legal entities, and positions the business for operational reinvestment and growth under new ownership.

Pamlico Capital Invests in Aite-Novarica Group

July 21, 2021

Financial Services

Pamlico Capital has made a growth investment in Aite-Novarica Group (ANG), the combined subscription research and advisory business formed from Aite Group and Novarica. As part of the partnership, executive Kurt Reisenberg will lead the combined company as CEO and ANG will use the capital to scale the platform and pursue complementary add-on acquisitions.

AVANT Acquires PlanetOne

May 10, 2022

Telecommunications

AVANT has acquired PlanetOne, combining the two IT and telecom channel businesses under the AVANT brand to expand partner enablement, sales capabilities and technology platforms. The deal folds PlanetOne's SENTIENT partner engagement platform and channel team into AVANT (a Pamlico Capital–backed platform) to accelerate scale across cloud, security, UCaaS and connectivity markets.

AVANT BIO (Fund II) Invests in Nomic Bio, PathPresenter and PL BioScience

September 28, 2024

Biotechnology

Growth equity firm AVANT BIO (Avant Bio Fund II LP) participated in three financing rounds: it joined Nomic Bio’s oversubscribed Series B, led PathPresenter’s $7.5M Series A, and joined PL BioScience’s €7.8M Series A. The investments support commercialization, scale-up of production and adoption of life‑science and healthtech solutions across proteomics, digital pathology, and xeno‑free cell culture media.

Court Square Capital Partners Invests in Connatix

July 19, 2021

Cloud & SaaS

Court Square Capital Partners has made a significant growth investment in Connatix, a New York–based video technology platform for publishers and advertisers. The investment will support Connatix's product innovation, strategic M&A initiatives, and international expansion while the company's founders remain in leadership and early investor Volition Partners stays invested.